Peptide Research Advancements 2025: Key Innovations to Watch
Share
From GLP-1 analogues outselling paracetamol to venom-inspired oncology leads, peptides are still the small molecules making big headlines. We’ve skimmed the journals so you don’t have to.
| Date / Journal | Key finding | Why it matters in the lab |
|---|---|---|
| Apr 2024 — Nature Biomedical Engineering | Engineered micro-peptides amplified anti-tumour immunity in pre-clinical breast-cancer models. | Expands the signalling uses of short chains beyond simple binding assays. |
| Dec 2024 — Pharmacological Research | Peptides isolated from Brazilian tarantula venom eliminated resistant melanoma cells in mice. | Wildlife remains an under-mined scaffold library. |
| Mar 2025 — Signal Transduction & Targeted Therapy | Review charts >80 clinical-stage peptide candidates and the rise of AI-assisted design. | Handy one-stop citation list when planning upcoming screens. |
People worth following
Andrew Huberman: Podcast episode (Jan 2025) covering benefits & risks of therapeutic peptides.
Derek Lowe (In the Pipeline blog): typically sceptical but never dull takes on cyclic-peptide synthesis headaches.
Compliance corner
All Nupex products are supplied exclusively for laboratory research use. They are not medicines, supplements or cosmetics. Please keep them in the fume cupboard rather than the fridge next to your lunch.